Mesoblast News

News on Mesoblast (Ticker: MSB) continually updated from thousands of sources around the net.

Thursday May 10 | BioSpace

New Teva Pharmaceutical Industries Limited Representative Joins...

Dr Weiner has been Teva's head of global research and development for over three decades, most recently as Chief R&D Officer and a member of the Teva Executive Committee.

Comment?

Tue Apr 17, 2012

BioSpace

Mesoblast Limited Release: Intervertebral Disc Repair Phase 2 Trial Update

This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure.

Comment?

Mon Feb 27, 2012

BioSpace

Half-year Results - Mesoblast Limited Posts Strong Cash Balance

Melbourne, Australia; 27 February 2012: Global regenerative medicine company, Mesoblast Limited , today reported cash reserves of $241 million for the 2012 financial half year reporting period ended 31 December 2011.

Comment?

Tue Jan 31, 2012

BioSpace

Mesoblast Limited Receives FDA Clearance for Phase 2 Clinical Trial...

Mesoblast Limited Receives FDA Clearance for Phase 2 Clinical Trial of Proprietary Stem Cell Therapy in Type 2 Diabetes Melbourne, Australia, and New York, USA: 31 January 2012: Mesoblast Limited today announced that it has received clearance from the United States Food and Drug Administration to begin a Phase 2 clinical trial of its proprietary ... (more)

Comment?